The global Veterinary Drugs for Companion Animals market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Veterinary drugs for companion animals refer to pharmaceutical products that are specifically designed and formulated for use in the treatment, prevention, or management of diseases, conditions, or health issues in pets or companion animals. These drugs are developed to address the unique physiological and medical needs of animals kept as companions, including dogs, cats, birds, rabbits, and other small animals.

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly ?6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 22%.

Infinity Market Research newest research report, the ?Veterinary Drugs for Companion Animals Industry Forecast? looks at past sales and reviews total world Veterinary Drugs for Companion Animals sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Drugs for Companion Animals sales for 2025 through 2031. With Veterinary Drugs for Companion Animals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Drugs for Companion Animals industry.

This Insight Report provides a comprehensive analysis of the global Veterinary Drugs for Companion Animals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Veterinary Drugs for Companion Animals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Veterinary Drugs for Companion Animals market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Drugs for Companion Animals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Drugs for Companion Animals.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Drugs for Companion Animals market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Injection
    Taking Class

Segmentation by Application:

    Farm
    Veterinary Clinic
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Zoetis
    Boehringer Ingelheim
    Merck Animal Health
    Elanco Animal Health
    Bayer Animal Health
    Virbac
    Dechra Veterinary Products
    Ceva
    Vetoquinol
    Meiji
    Ouro Fino Saude
    Parnell